Oncology & Cancer

Anti-cancer drug's mode of operation deciphered

Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. ...

Diseases, Conditions, Syndromes

Study is first to identify potential therapeutic targets for COVID-19

A team from Lawson Health Research Institute and Western University are the first in the world to profile the body's immune response to COVID-19. By studying blood samples from critically ill patients at London Health Sciences ...

Oncology & Cancer

New MDS subtype proposed based on presence of genetic mutation

In a special report published today in the journal Blood, an international working group of experts in myelodysplastic syndromes (MDS) proposes—for the first time—the recognition of a distinct subtype of MDS based on ...

page 1 from 9